Lundbeck Eyes US, China Investment as Drug Rewards Lag in Europe

H. Lundbeck A/S will focus its capital investments on the US and China rather than Europe as the region faces growing pressure to incentivize innovation, according to the Danish drugmaker’s chief executive officer.Read More